{"id":"W4410810218","doi":"10.1200/jco.2025.43.16_suppl.e12598","title":"A phase 1 study of abemaciclib and niraparib as neoadjuvant therapy in hormone receptor positive and HER2 negative breast cancer.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Oncology; Hormone receptor; Internal medicine; Cancer; Hormone therapy; Neoadjuvant therapy; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001281357,0.0001697893,0.001751808,0.0002069747,0.00003310256,0.000006012427,0.00009655878,0.0002038836,0.00005246925],"category_scores_gemma":[0.0005750348,0.0001207859,0.0001195098,0.000282777,0.0004246575,0.0001448462,0.00005368967,0.0008072213,5.293617e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001515724,"about_ca_system_score_gemma":0.0008895521,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005379033,"about_ca_topic_score_gemma":0.0002014861,"domain_scores_codex":[0.9971337,0.0004959028,0.001712913,0.0002419166,0.0002253959,0.0001901152],"domain_scores_gemma":[0.9961818,0.001811437,0.001194982,0.0001313009,0.0004754309,0.0002049775],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.06940435,0.009203378,0.0680658,0.00001840606,0.0009753554,0.0002202829,0.002480406,0.00000531309,0.002570699,0.00004746838,0.0001766778,0.8468319],"study_design_scores_gemma":[0.1009122,0.06870311,0.820272,0.0004197434,0.0002481421,0.0003463874,0.004968941,0.00003018502,0.0005263365,0.0008438581,0.002608138,0.0001209299],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.985018,0.005203504,0.00003556692,0.008544019,0.0003815434,0.0005415287,0.00001956586,0.000005111968,0.0002511809],"genre_scores_gemma":[0.98974,0.007388352,0.0007224993,0.001724763,0.0003063673,0.00001554282,6.344076e-7,0.0000130216,0.00008879994],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8467109,"threshold_uncertainty_score":0.4925507,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06079761404456113,"score_gpt":0.497628338165247,"score_spread":0.4368307241206859,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}